is berberine a semaglutide RESEARCH WEDNESDAY has been described as “Nature's Ozempic” across social media. recent systematic review and meta-analysis combined data from 23 randomised controlled trials and found statistically significant reductions in Berberine vs Semaglutide Benefits and

A warning that ignores that is just noise

One in five semaglutide users experiences vomiting versus roughly one in seven tirzepatide users

2023, Lancet) shows 15.7 percent weight loss in patients with type 2 diabetes

BPC-157 Dosing in Hepatic Impairment: Evidence, Risks, and Clinical Guidance At a glance No FDA-approved formulation / BPC-157 is available only through 503A compounding pharmacies Zero published human RCTs evaluating BPC-157 in hepatic impairment populations Animal models show hepatoprotective effects against NSAID, alcohol, and toxin-induced liver damage Standard compounded dose range is 200-500 mcg/day subcutaneously or intramuscularly Suggested starting dose in hepatic impairment is 200-250 mcg/day subcutaneously Peptides are cleared primarily by proteolytic degradation, not hepatic CYP450 metabolism Liver enzyme monitoring (ALT, AST, bilirubin) recommended at baseline and every 2-4 weeks BPC-157 has shown cytoprotective effects on gastric and intestinal mucosa in over 20 animal studies The FDA has not established hepatic dosing adjustments for BPC-157 Cycle length in liver-compromised patients: 4-6 weeks with reassessment before continuation What Is BPC-157 and How Does It Work

Nature 487, 443448